CorPath™ 200: Robotically-Assisted Percutaneous Coronary Intervention (PCI)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01076036 |
Recruitment Status :
Completed
First Posted : February 25, 2010
Results First Posted : September 7, 2015
Last Update Posted : September 7, 2015
|
Sponsor:
Corindus Inc.
Information provided by (Responsible Party):
Corindus Inc.
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: N/A; Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment |
Condition |
Coronary Artery Disease |
Intervention |
Device: CorPath 200 |
Enrollment | 8 |
Participant Flow
Recruitment Details | February-March 2011 at CORBIC, Envigado, Colombia |
Pre-assignment Details |
Arm/Group Title | Group 1 |
---|---|
![]() |
Group 1 was treated using the CorPath device. |
Period Title: Overall Study | |
Started | 10 |
# of Procedures | 8 |
Complete CorPath Procedures | 8 |
Completed | 8 |
Not Completed | 2 |
Reason Not Completed | |
Didn't meet inclusion/exclusion criteria | 2 |
Baseline Characteristics
Arm/Group Title | Investigational | |
---|---|---|
![]() |
CorPath® 200 System | |
Overall Number of Baseline Participants | 8 | |
![]() |
[Not Specified]
|
|
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 8 participants | |
<=18 years |
0 0.0%
|
|
Between 18 and 65 years |
3 37.5%
|
|
>=65 years |
5 62.5%
|
|
Age, Continuous
Mean (Standard Deviation) Unit of measure: Years |
||
Number Analyzed | 8 participants | |
67.8 (10.7) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 8 participants | |
Female |
5 62.5%
|
|
Male |
3 37.5%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||
Colombia | Number Analyzed | 8 participants |
8 |
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title: | Michail M. Pankratov, MD, PhD, Vice President of Clinical & Regulatory Affairs |
Organization: | Corindus, Inc |
Phone: | 508-653-3335 ext 206 |
EMail: | Michail.Pankratov@Corindus.com |
Responsible Party: | Corindus Inc. |
ClinicalTrials.gov Identifier: | NCT01076036 |
Other Study ID Numbers: |
Corindus-Corbic-2010 |
First Submitted: | February 24, 2010 |
First Posted: | February 25, 2010 |
Results First Submitted: | July 31, 2012 |
Results First Posted: | September 7, 2015 |
Last Update Posted: | September 7, 2015 |